AI Summary & Key Takeaways
AI InsightIn our case report we attempted to analyze clinical characteristics of a patient with vulvar carcinoma following cervical cancer treatment with particular focus on the etiology such as HPV, radiation therapy and genetic instability, prognostic factors and treatment result.
📌 3 Key Takeaways
Abstract
Recently with more effective treatment strategies for cervical cancer, larger numbers of patients survive and greater incidence of second malignant neoplasms have been diagnosed. Patients after treatment of cervical cancer have a 2.5-37% lifetime risk of developing a second squamous cell malignancy of the lower genital tract (1). This risk is 5 to 12 times higher compared to general population (2). In our case report we attempted to analyze clinical characteristics of a patient with vulvar carcinoma following cervical cancer treatment with particular focus on the etiology such as HPV, radiation therapy and genetic instability, prognostic factors and treatment result.
Özet
Son zamanlarda serviks kanseri için etkili tedavi stratejileri uygulanması ile daha çok sayıda hastanın sağ kalması sağlanmış ve ikinci malign neoplazma insidansı artmıştır. Serviks kanseri tedavisi olmuş hastalarda hayat boyu alt genital sistemde ikinci skuamöz hücreli kanser gelişme riski %2.5-37'dir (1). Bu risk genel popülasyona kıyasla 5 ilâ 12 kat kadar daha yüksektir (2). Olgu sunumumuzda serviks kanserini takiben vulva kanseri gelişen olguda HPV, radyoterapi ve genetik kararsızlık gibi etyolojik faktörlere odaklanarak, prognostik faktörleri ve tedavi sonucunu analiz etmeyi amaçladık.